Vitrafy Life Sciences (ASX:VFY) said its non-underwritten share purchase plan targeting proceeds of about AU$2 million is now open and will run until July 3, according to a Friday filing with the Australian bourse.
The plan is open to shareholders of record as of June 11 at a price of AU$2.60 per share.
The company's shares rose past 1% in recent Friday trade.